Goodwin @ JPMorgan

Learn with Us: Goodwin + KPMG @ JPMorgan Symposium at the St. Regis Hotel

The St. Regis San Francisco
125 3rd Street
San Francisco, CA 94103

8:30 am – 8:45 am  Welcome Remarks

• Mitch Bloom, Chair, Life Sciences Practice, Goodwin
• Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)

Burst 1: New Frontiers in Digital Diagnostics & Medtech

8:50 am – 9:05 am  Current State of the Healthcare Sector & Regulations

• Roger Cohen, Partner, Goodwin

9:10 am – 9:55 am  New Frontiers in MedTech Space on the Global Stage: What are the Challenges in IP, Regulatory and Commercial

• Kristin Ciriello Pothier, Global Healthcare and Life Sciences Strategy Leader, KPMG (Moderator)
• Nicholas Mitrokostas, Partner, Goodwin
• Stefan Scherer, Global Head of Experimental Medicine, GlaxoSmithKline (GSK)

10:00 am – 10:45 am  Panel: Issues Facing Therapeutic Companies Using ML and AI in Drug Discovery Methods

• Danielle Lauzon, Partner, Goodwin (Moderator)
• David Berry, General Partner, Flagship; CEO, Integral
• Dan Housman, Co-founder, CTO Graticule, Co-founder Courage Therapeutics

Keynote Speech

10:55 am – 11:40 am  Keynote Speaker - Stéphane Bancel, CEO, Moderna

11:40 am – 12:10 pm  Lunch Break

Burst 2: Europe Unleashed

12:10 pm – 12:40 pm  The Evolving Landscape for Growth-Stage Venture Funding in Europe

• Sophie McGrath, Partner, Goodwin (Moderator)
• Francesco De Rubertis, Co-Founder and Partner, Medicxi

12:45 pm – 1:15 pm  Maximizing Returns through Structured M&As

• Graham Defries, Partner, Goodwin (Moderator)

Burst 3: Wins and Learnings of the Latest IPO Exits

1:20 pm – 1:40 pm  2020 Vision for the IPO Market

1:40 pm – 2:10 pm  Traditional US IPO Route: “The Two Minute Drill” to Complete a Successful IPO in the First Six Months of the Year

• Janet Lehman, National Leader, VC Life Sciences, KPMG (Moderator)
• Tom Koncsics, Partner, KPMG
• Jack Cassel, Vice President, Nasdaq

2:15 pm – 2:45 pm  Hong Kong IPO: Seizing Opportunities at the World's No. 1 Fundraising Hub

• Wendy Pan, Partner, Goodwin Hong Kong (Moderator)
• Irene Chu, Partner, Head of New Economy and Life Sciences, Hong Kong, KPMG China

2:50 pm – 3:20 pm  Alternatives to U.S. IPO: Reverse Mergers and Direct Listings

• Deepa Rich, Partner, Goodwin (Moderator)
• Gerry Schemidt, Partner, Audit, KPMG
• Mitchell H. Gold, Executive Chairman & CEO, Alpine Immune Sciences

3:20 pm – 3:30 pm  Coffee & Networking

Burst 4: Trends in Biopharma

3:30 pm – 4:10 pm  Evaluating and Partnering New Technologies and Emerging Business Models

• Kingsley Taft, Partner, Goodwin (Moderator)
• Jeffrey Stoll, Principal, National Life Sciences Strategy Leader, KPMG

Burst 5: Mergers and Acquisitions

4:15 pm – 5:15 pm  The Brave New World of Antitrust in Life Sciences M&A

• Stuart Cable, Partner, Goodwin (Moderator)
• Lisa Haddad, Partner, Goodwin
• Andrea Murino, Partner, Goodwin

5:15 pm – 6:15 pm  Cocktails & Networking

Goodwin knows that succeeding in the life sciences industry is as much about strategy and execution as it is about research and development. In this highly competitive business, you need more than the best and brightest ideas - you need a legal and strategic partner that understands the challenges of securing funding, safeguarding intellectual property, establishing partnerships, bringing new products to market, opening up new revenue streams, and protecting existing products line.

Goodwin can help. We know the market, the players and the science. With a full service team of highly experienced lawyers resident in key life sciences hubs, Goodwin helps clients find the strategic paths that foster growth and minimize risk across all phases of the corporate life cycle.

Click here to learn more about Gooodwin's Life Sciences practice.